HUTCHMED (China) Limited Sponsored ADR (HCM)
(Delayed Data from NSDQ)
$16.03 USD
-1.26 (-7.29%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $16.05 +0.02 (0.12%) 5:04 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Balance Sheet
Fiscal Year End for HUTCHMED China Limited Sponsored ADR falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 886 | 631 | 1,012 | 435 | 217 |
Receivables | 132 | 152 | 165 | 75 | 59 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 50 | 57 | 36 | 20 | 16 |
Other Current Assets | 28 | 0 | 0 | 1 | 25 |
Total Current Assets | 1,097 | 840 | 1,212 | 531 | 317 |
Net Property & Equipment | 100 | 76 | 41 | 24 | 22 |
Investments & Advances | 48 | 74 | 76 | 140 | 99 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 16 |
Deferred Charges | 15 | 15 | 9 | 2 | 1 |
Intangibles | 0 | 0 | 0 | 0 | 3 |
Deposits & Other Assets | 15 | 16 | 22 | 20 | 1 |
Total Assets | 1,280 | 1,029 | 1,373 | 724 | 465 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 27 | 0 | 0 |
Accounts Payable | 36 | 71 | 41 | 32 | 24 |
Current Portion Long-Term Debt | 31 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 3 | 1 | 16 | 1 | 2 |
Other Current Liabilities | 329 | 282 | 228 | 123 | 84 |
Total Current Liabilities | 403 | 354 | 312 | 158 | 113 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 71 | 3 | 3 | 6 | 3 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 48 | 18 | 0 | 27 | 27 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 11 | 13 | 12 | 8 | 6 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 536 | 393 | 333 | 205 | 152 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 87 | 86 | 86 | 73 | 67 |
Capital Surplus | 1,522 | 1,497 | 1,505 | 822 | 515 |
Retained Earnings | -871 | -971 | -610 | -416 | -290 |
Other Equity | 5 | 25 | 58 | 39 | 21 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 743 | 637 | 1,040 | 519 | 313 |
Total Liabilities & Shareholder's Equity | 1,280 | 1,029 | 1,373 | 724 | 465 |
Total Common Equity | 743 | 637 | 1,040 | 519 | 313 |
Shares Outstanding | 174.20 | 172.90 | 172.90 | 133.30 | 133.30 |
Book Value Per Share | 4.27 | 3.68 | 6.01 | 3.89 | 2.35 |
Fiscal Year End for HUTCHMED China Limited Sponsored ADR falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 802 | -99,999 | 886 | -99,999 | 856 |
Receivables | 172 | NA | 132 | NA | 158 |
Notes Receivable | NA | NA | 0 | NA | NA |
Inventories | 46 | NA | 50 | NA | 54 |
Other Current Assets | 28 | NA | 28 | NA | 22 |
Total Current Assets | 1,048 | NA | 1,097 | NA | 1,090 |
Net Property & Equipment | 95 | NA | 100 | NA | 97 |
Investments & Advances | 81 | NA | 48 | NA | 38 |
Other Non-Current Assets | NA | NA | 0 | NA | 33 |
Deferred Charges | NA | NA | 15 | NA | NA |
Intangibles | NA | NA | 0 | NA | NA |
Deposits & Other Assets | 37 | NA | 15 | NA | 40 |
Total Assets | 1,261 | NA | 1,280 | NA | 1,298 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 0 | NA | NA |
Accounts Payable | 293 | NA | 36 | NA | 55 |
Current Portion Long-Term Debt | 26 | NA | 31 | NA | NA |
Current Portion Capital Leases | NA | NA | 0 | NA | NA |
Accrued Expenses | NA | NA | 0 | NA | NA |
Income Taxes Payable | NA | NA | 3 | NA | NA |
Other Current Liabilities | 54 | NA | 329 | NA | 286 |
Total Current Liabilities | 373 | NA | 403 | NA | 341 |
Mortgages | NA | NA | 0 | NA | NA |
Deferred Taxes/Income | 61 | NA | 71 | NA | 97 |
Convertible Debt | NA | NA | 0 | NA | NA |
Long-Term Debt | 56 | NA | 48 | NA | 40 |
Non-Current Capital Leases | NA | NA | 0 | NA | NA |
Other Non-Current Liabilities | 19 | 11 | NA | 19 | |
Minority Interest (Liabilities) | NA | NA | 0 | NA | NA |
Total Liabilities | 509 | NA | 536 | NA | 497 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | NA | NA |
Common Stock (Par) | 87 | NA | 87 | NA | 87 |
Capital Surplus | 1,508 | NA | 1,522 | NA | 1,506 |
Retained Earnings | -845 | NA | -871 | NA | -803 |
Other Equity | 2 | NA | 5 | NA | 10 |
Treasury Stock | NA | NA | 0 | NA | NA |
Total Shareholder's Equity | 752 | NA | 743 | NA | 800 |
Total Liabilities & Shareholder's Equity | 1,261 | NA | 1,280 | NA | 1,298 |
Total Common Equity | 100,751 | 0 | 743 | 0 | 100,799 |
Shares Outstanding | 174.20 | 174.20 | 174.20 | 174.20 | 173.20 |
Book Value Per Share | 578.36 | 0.00 | 4.27 | 0.00 | 581.98 |